Viagra could double risk of hearing loss

NEW YORK (Reuters Health) - Is an erection worth becoming hard of hearing?
 

Vet says NY dog needs Viagra for heart condition

NY animal shelter seeks Viagra donations to treat a pit bull with a heart condition. A New York animal shelter is seeking donations of Viagra to treat a pit bull with a heart condition. Staff members at the Little Shelter Animal Rescue and Adoption Center in Huntington, on Long Island, say 6-year-old Ingrid needs two of the little blue pills every day or she will risk heart failure. They said a vet suggested it.
 

Texans LB Cushing denies drug use

Texans LB Cushing says he tested positive for HCG, denies using any banned substance. Houston Texans linebacker Brian Cushing said Thursday he never used any banned substances even though he tested positive for a performance-enhancing drug.
 

Prostate cancer therapies all affect quality of life

NEW YORK (Reuters Health) - The various forms of prostate cancer treatment -- from surgery to radiation to hormones -- can all have long-term effects on men's quality of life when it comes to sexual function and urinary problems, a new study finds.
 

FDA Approves New Prostate Cancer Therapy

Treatment results in slightly extended life expectancy. The Food and Drug Administration (FDA) has approved Provenge (sipuleucel-T), a treatment that stimulates a patient's own immune system to respond against the cancer.
 

FDA probes risks of HIV, prostate, other drugs

WASHINGTON (Reuters) - U.S. regulators are investigating potential risks from Abbott Laboratories Inc's HIV drug Kaletra, GlaxoSmithKline Plc's prostate drug Avodart and other medicines.
 

U.S. reviews diabetes, heart risk with prostate drugs

WASHINGTON (Reuters) - The U.S. Food and Drug Administration is examining if certain hormone treatments for men with prostate cancer pose a greater risk of diabetes or heart problems than other therapies.
 

Report: Philadelphia VA hospital lacked review

The prostate cancer program at the Veterans Affairs Department's medical center in Philadelphia, where 97 patients were given an incorrect radiation dose, went four years without a peer review or quality assessment, the agency's internal watchdog said Monday.
 

Report: Philadelphia VA hospital lacked review

VA investigation says Philadelphia hospital went 4 years without peer review. The prostate cancer program at the Veterans Affairs Department's medical center in Philadelphia, where 97 patients were given an incorrect radiation dose, went four years without a peer review or quality assessment, the agency's internal watchdog said Monday.
 

FDA probes diabetes risk with prostate cancer meds

The Food and Drug Administration is looking into data suggesting a group of prostate cancer drugs increase the risk of diabetes and heart disease.
 

FDA probes diabetes risk with prostate cancer meds

FDA warns that early evidence shows links between prostate cancer drugs and diabetes. The Food and Drug Administration is looking into data suggesting a group of prostate cancer drugs increase the risk of diabetes and heart disease.
 

Goldman Sachs, Transocean are active movers

Goldman Sachs, Transocean, Halliburton, D.R. Horton among big market movers Friday. Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and Nasdaq Stock Market:
 

Armstrong and girlfriend expecting another child

American cyclist Lance Armstrong, a testicular cancer survivor and seven time Tour de France champ, announced that he and his girlfriend are expecting their second child in a year.
 

Gene scan shows man's risk for heart attack, cancer

WASHINGTON (Reuters) - A California college professor who sequenced his own genome has had it analyzed -- and discovered he has a high risk of dropping dead of a sudden heart attack, as well as a high prostate cancer risk.
 

FDA approves breakthrough cancer therapy Provenge

Novel drug for prostate cancer rallies body's immune system against tumors. A first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease received federal approval Thursday, offering an important alternative to more taxing treatments like chemotherapy.
 

US approves new treatment for advanced prostate cancer

US regulators have approved a ground-breaking treatment for advanced prostate cancer that uses a patient's own immune system to fight the disease, officials said Thursday.
 

Business Highlights

Stocks climb on earnings, drop in jobless claims
 

FDA approves breakthrough cancer therapy Provenge

A first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease received federal approval Thursday, offering an important alternative to more taxing treatments like chemotherapy.
 

FDA approves Dendreon's cancer drug Provenge

FDA approved Dendreon's Provenge drug to stimulate immune system against prostate cancer. The Food and Drug Administration has approved a first-of-a-kind prostate cancer treatment that uses the body's immune system to fight the disease, offering an important alternative to decades-old approaches.
 

Brazil court rules Viagra patent ends in June

Brazil's top appeals court has ruled that the patent on Viagra expires next month in the South American nation, a year earlier than argued by the manufacturer.